induction final maturation oocytes procedure usually performed part controlled ovarian hyperstimulation render oocytes fully developed thereby resulting optimal pregnancy chances basically replacement luteinizing hormone lh surge whose effects include final maturation natural menstrual cycles main medications used induction final maturation human chorionic gonadotropin hcg gnrh agonist fresh rather frozen autologous cycles vitro fertilization final oocyte maturation triggering gnrh agonist instead hcg decreases risk ovarian hyperstimulation syndrome decreases live birth rate cycles followed oocyte donation use gnrh agonists instead hcg decreases risk ovarian hyperstimulation syndrome evidence difference live birth induction final maturation also initiates mechanisms eventually result ovulation thereby makes oocytes destined undergo ovulation unless artificial oocyte retrieval performed first therefore induction final maturation also called triggering oocyte release ovary administration pharmaceutical drugs induce final maturation colloquially called giving trigger shot even plan perform artificial oocyte retrieval administration drug trigger oocyte release without oocyte retrieval results predictable time ovulation interval drug administration ovulation depending type drug avails sexual intercourse intrauterine insemination iui conveniently scheduled ovulation likely time achieve ovulation induction using clomifene intended conception sexual intercourse however triggering oocyte release shown decrease pregnancy chances compared frequent monitoring lh surge therefore cases triggering oocyte release best reserved women require iui lh monitoring proves difficult may also used lh monitoring hasnt shown lh surge cycle day cycle day first day preceding menstruation ovarian follicle mm vitro fertilization ivf induction final maturation avails egg retrieval eggs fully maturecitation needed ivf final maturation induction preceded controlled ovarian hyperstimulation suggested size ovarian follicles least mm serum estradiol level nmoll commencing final maturation induction better prospects follicle size mm serum estradiol level medications used final maturation andor release oocytes include final maturation induction using gnrh agonist results substantial decrease risk ovarian hyperstimulation syndrome ohss cochrane review estimated using gnrh agonist instead hcg ivf decreases risk mild moderate severe ohss odds ratio approximately review estimated woman risk mild moderate severe ohss use hcg risk ohss use gnrh agonist would however using gnrh agonist lower live birth rate using hcg autologous oocyte transfers rather ones using oocyte donation cochrane review autologous oocyte transfers estimated gnrh agonist compared hcg gives odds ratio pregnancy approximately estimated woman chance achieving live birth use hcg chance live birth use gnrh agonist would likewise using gnrh agonist instead hcg associated lower ongoing pregnancy rate pregnancy beyond weeks seen hcg odds ratio higher rate early less weeks miscarriage odds ratio however higher pregnancy rate using hcg found receiving luteal support without luteinizing hormone activity progesterone final maturation induction using gnrh agonist recommended women cancer undergoing fertility preservation ovarian hyperstimulation syndrome associated increased risk arterial thrombotic events stroke myocardial infarction peripheral arterial embolism risk add already increased risk caused using hcg versus gnrh agonist effect risk multiple also difference found regimens regarding live birth rate ongoing pregnancy rate controlled ovarian hyperstimulation followed oocyte httpsenwikipediaorgwikifinalmaturationinduction